Medicine and Dentistry
Patient
100%
Lymph Duct
55%
Programmed Death-Ligand 1
55%
Lung
55%
Mortality
55%
Vascular Bundle
39%
Prospective Study
34%
C Reactive Protein
34%
Malignant Pleural Effusion
34%
Pneumothorax
33%
Interstitial Lung Disorder
33%
Bleeding
33%
Lung Cancer
30%
Neoplasm
29%
Diagnosis
26%
Tissue Sampling
22%
Mortality Rate
22%
Overall Survival
20%
Inpatient
18%
Lobectomy
15%
Prognostic Factor
15%
Non Small Cell Lung Cancer
15%
Lymph Node
15%
Multivariate Analysis
14%
Biological Marker
13%
Total Lung Capacity
11%
Invasive Procedure
11%
Fatality
11%
Thorax Drainage
11%
Carbon Monoxide
11%
Adverse Event
11%
Prematurity
11%
Lung Biopsy
11%
Morbidity
11%
Examination
11%
Observation
11%
Monitoring
11%
Evaluation Study
11%
Complication
11%
Clinical Trial
11%
Adenocarcinoma
7%
Lymph
7%
Video-Assisted Thoracoscopic Surgery
7%
Cell Dedifferentiation
7%
Survival Rate
7%
Diseases
7%
Recurrent Disease
7%
Surgery
7%
Malignant Neoplasm
7%
Adjuvant Therapy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
23%
Neoplasm
15%
Non Small Cell Lung Cancer
15%
Adenocarcinoma
7%
Diseases
7%
Squamous Cell Carcinoma
7%
Recurrent Disease
7%
Survival Rate
7%
Malignant Neoplasm
7%
Death
7%